Results 181 to 190 of about 24,217 (252)

Prostate cancer screening and evidence: the role of overall survival. [PDF]

Transl Androl Urol
Takahashi T.
europepmc   +1 more source

Malignant/Sarcomatous Transformation of Mixed Epithelial and Stromal Tumor of the Kidney: A Case Report

IJU Case Reports, Volume 9, Issue 4, July 2026.
ABSTRACT Introduction Malignant transformation of mixed epithelial and stromal tumors of the kidney (MESTK) is extremely rare. Case Presentation A 39‐year‐old man with gross hematuria was suspected to have renal cell carcinoma, measuring 13 cm in diameter. No distant metastases were observed.
Kentaro Arinami, Kozue Ito, Go Hasegawa, Yurie Takizawa, Yohei Ikeda, Noboru Hara, Tsutomu Nishiyama   +6 more
wiley   +1 more source

Penile pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma: a case report and literature review. [PDF]

Front Oncol
Wang W, Liang C, Yang H, Wang B, Tang J, Zhu Y, Sun J, Gao Q.   +7 more
europepmc   +1 more source

Neuroendocrine Transformation Without PSA Elevation in High‐Risk Metastatic Castration‐Sensitive Prostate Cancer Under Androgen Receptor Signaling Inhibition: A Case Report

IJU Case Reports, Volume 9, Issue 4, July 2026.
ABSTRACT Introduction Neuroendocrine prostate cancer is a rare and highly aggressive variant of prostate cancer with a poor prognosis. We report a case in which metastatic castration‐sensitive prostate cancer directly transformed into neuroendocrine prostate cancer without a corresponding increase in prostate‐specific antigen.
Yoshihiro Nakagami, Shintaro Ohnuma, Masashi Tamaoka, Tatsuki Inoue, Motoki Yamagishi, Kazuhiko Oshinomi, Masakazu Nagata, Yasuyuki Oohira, Toshiko Yamochi, Takashi Fukagai   +9 more
wiley   +1 more source

Update on penile prosthesis. [PDF]

Asian J Androl
Busetto GM, Bettocchi C.
europepmc   +1 more source

Belzutifan for Metastatic TFE3‐Rearranged Renal Cell Carcinoma With Pulmonary Metastases: A Case Report

IJU Case Reports, Volume 9, Issue 4, July 2026.
ABSTRACT Introduction Belzutifan is effective in patients with previously treated advanced clear cell renal cell carcinoma. However, evidence for its use in non‐clear cell renal cell carcinoma remains limited. Case Presentation A 33‐year‐old Japanese woman underwent total nephrectomy for a 10‐cm renal tumor with lung metastases.
Kazutaka Nakamura, Akihiro Kumono, Yuki Kobari, Atsuko Seki, Takayuki Nakayama, Hironori Fukuda, Kazuhiko Yoshida, Junpei Iizuka, Yoji Nagashima, Toshio Takagi   +9 more
wiley   +1 more source

Testicular Assessment in a Selected Group of Young Buffaloes Using Doppler Ultrasonography. [PDF]

Vet Med Sci
Albuquerque RDS, Santos JBD, Lima MM, Silva AOAD, Rossy KDC, Cunha MSE, Santos GMAD, Monteiro FDO, Borges LPB, Conceição MEBAMD, Monteiro BM, Viana RB, Coutinho LN, Miranda MDS, Teixeira PPM.   +14 more
europepmc   +1 more source

A Case of Acalculous Cholecystitis During Lenvatinib Plus Pembrolizumab Therapy for Advanced Renal Cell Carcinoma

IJU Case Reports, Volume 9, Issue 4, July 2026.
ABSTRACT Introduction Lenvatinib plus pembrolizumab is a standard first‐line therapy for advanced renal cell carcinoma (RCC), and acute acalculous cholecystitis is a rare adverse event. Case Presentation A 60‐year‐old woman with metastatic TFE3‐positive non–clear cell RCC, classified as poor risk by the International Metastatic RCC Database Consortium (
Erika Soga, Go Noguchi, Kota Kobayashi, Rio Shibata, Ryosuke Jikuya, Tomoyuki Tatenuma, Mitsuru Komeya, Hiroki Ito, Hisashi Hasumi, Kazuhide Makiyama   +9 more
wiley   +1 more source

Is it time to say "shorter, safer, and smarter"?-interpreting early toxicity data from the PACE-C non-inferiority trial. [PDF]

Transl Androl Urol
Baccaglini W, de Carvalho IT.
europepmc   +1 more source

Significant Response to Nivolumab Plus Ipilimumab in Metastatic Mucinous Tubular and Spindle Cell Carcinoma: A Case Report

IJU Case Reports, Volume 9, Issue 4, July 2026.
ABSTRACT Introduction Mucinous tubular and spindle cell carcinoma (MTSCC) is a rare renal cell carcinoma subtype that is typically indolent but may exhibit aggressive behavior. No standard systemic therapy has been established for metastatic MTSCC. Case Presentation A 71‐year‐old woman underwent retroperitoneoscopic radical left nephrectomy for MTSCC ...
Sho Shimasaki, Shinkuro Yamamoto, Mitsuko Iguchi, Erika Yamashita, Kaya Atagi, Yuhei Shiba, Satoshi Fukata, Hirofumi Satake, Takashi Karashima, Keiji Inoue   +9 more
wiley   +1 more source